Publications by authors named "Pengde Lu"

Claim this Profile
U
Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma".
Pengde Lu, Ning Wang

Clin Mol Hepatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu

Mol Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
20(S)- Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis.
Jinfen Chen, Pengde Lu, Jiayue Liu, Li Yang, Yiyang Li

Phytother Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical studies of licorice in ulcerative colitis: A systematic review with meta-analysis and network pharmacology.
Peng-De Lu, Meng-Chen Yuan, Xing-Ping Quan, Jin-Fen Chen, Yong-Hua Zhao

J Ethnopharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin V-Modified Platelet-Biomimetic Nanomedicine for Targeted Therapy of Acute Ischemic Stroke.
Xingping Quan, Yan Han, Pengde Lu, Yuanfu Ding, Qingfu Wang

Adv Healthc Mater· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines.
Peng-De Lu, Yong-Hua Zhao

Chin Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis